Valuation BioHarvest Sciences Inc. Canadian Securities Exchange
Stocks
BHSC
CA13767B1013
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3500 CAD | +6.06% |
|
-2.94% | +46.67% |
Company Valuation: BioHarvest Sciences Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 75.75 | 107.1 | 117.6 | 61.43 | - | - |
| Change | - | 41.36% | 9.8% | -47.75% | - | - |
| Enterprise Value (EV) | 75.75 | 107.1 | 117.6 | 61.43 | 61.43 | 61.43 |
| Change | - | 41.36% | 9.8% | -47.75% | 0% | 0% |
| P/E | -5.28x | -7.73x | -8.65x | -6.65x | -16.4x | 6.69x |
| PBR | - | - | - | - | - | - |
| PEG | - | 0.3x | 0.3x | 0.2x | 0.3x | -0x |
| Capitalization / Revenue | - | 4.25x | 3.41x | 1.43x | 1.04x | 0.71x |
| EV / Revenue | - | 0x | 0x | 1.43x | 1.04x | 0.71x |
| EV / EBITDA | - | -0x | -0x | -12x | 206x | 4.58x |
| EV / EBIT | - | -0x | -0x | -9.32x | -37.5x | 6.14x |
| EV / FCF | - | -0x | -0x | -4.26x | -13.3x | 8.82x |
| FCF Yield | - | -8.89% | -8.15% | -23.5% | -7.54% | 11.3% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.05 | -0.8 | -0.6 | -0.4075 | -0.165 | 0.405 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 25.19 | 34.51 | 42.89 | 58.96 | 86.86 |
| EBITDA 1 | - | -5.738 | -3.951 | -5.134 | 0.2975 | 13.42 |
| EBIT 1 | - | -6.989 | -5.575 | -6.588 | -1.638 | 9.997 |
| Net income 1 | -12.56 | -12.91 | -11.14 | -9.266 | -3.773 | 10.31 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 5.539 | 6.180 | 5.190 | 2.710 | 2.710 | 2.710 |
| Nbr of stocks (in thousands) | 13,677 | 17,328 | 22,654 | 22,668 | - | - |
| Announcement Date | 4/30/24 A | 3/31/25 A | 3/31/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.4x | 1.96x | 12.81x | 5.23% | 13.71B | |
| 24.64x | 1.61x | 9.69x | 2.58% | 5.34B | |
| 16.26x | 3.36x | 10.33x | 5.59% | 4.77B | |
| 19.56x | - | - | 1.19% | 4.34B | |
| 17.86x | 2.53x | 10.98x | 2.8% | 3.54B | |
| 15.3x | 3.02x | 12.86x | 5.26% | 1.9B | |
| Average | 18.34x | 2.49x | 11.33x | 3.78% | 5.6B | |
| Weighted average by Cap. | 18.19x | 2.26x | 11.62x | 4.08% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BHST Stock
- BHSC Stock
- Valuation BioHarvest Sciences Inc.
Select your edition
All financial news and data tailored to specific country editions
